Bolt Biotherapeutics, Inc.
BOLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641281
In the last 90 days, Bolt Biotherapeutics, Inc. insiders filed 2 open-market purchases and 3 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $2.31M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Bolt Biotherapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 44
- −12 vs. Q3 2022
- Shares held
- 20.6M
- −6.20M (−23.1%) vs. Q3 2022
- Total value
- $26.8M
- −$12.9M (−32.5%) vs. Q3 2022
- New holders
- 1
- 15 more added
- Sold out
- 13
- 12 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BOLT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $2.31M |
| Q1 2026 | 24 | $2.49M |
| Q4 2025 | 21 | $3.30M |
| Q3 2025 | 24 | $4.28M |
| Q2 2025 | 25 | $5.10M |
| Q1 2025 | 30 | $7.33M |
| Q4 2024 | 38 | $9.99M |
| Q3 2024 | 32 | $12.2M |
| Q2 2024 | 37 | $17.0M |
| Q1 2024 | 39 | $33.6M |
| Q4 2023 | 40 | $27.0M |
| Q3 2023 | 35 | $25.5M |
| Q2 2023 | 40 | $32.1M |
| Q1 2023 | 41 | $32.4M |
| Q4 2022 | 44 | $26.8M |
| Q3 2022 | 56 | $39.7M |
| Q2 2022 | 62 | $54.8M |
| Q1 2022 | 66 | $79.3M |
| Q4 2021 | 62 | $164.6M |
| Q3 2021 | 72 | $449.1M |
| Q2 2021 | 61 | $513.8M |
| Q1 2021 | 70 | $1.04B |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Bolt Biotherapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 100 | $0 | 0.00% | −381−79.2% | Reduced |
| Salem Investment Counselors Inc | 40 | $52 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 43 | $56 | 0.00% | −450−91.3% | Reduced |
| Wells Fargo & Company | 149 | $194 | 0.00% | +4+2.8% | Added |
| Northwestern Mutual Wealth Management Co | 400 | $520 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 798 | $1.04K | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 1,675 | $2.18K | 0.00% | +1,536+1,105.0% | Added |
| Tower Research Capital LLC (TRC) | 2,217 | $3.00K | 0.00% | −16,320−88.0% | Reduced |
| Federated Hermes, Inc. | 4,029 | $5.24K | 0.00% | +1,886+88.0% | Added |
| Bank of New York Mellon Corp | 12,629 | $16.4K | 0.00% | −56−0.4% | Reduced |
| Stifel Financial Corp | 14,014 | $18.2K | 0.00% | −51−0.4% | Reduced |
| JPMorgan Chase & Co | 19,908 | $26.0K | 0.00% | +17,544+742.1% | Added |
| Susquehanna International Group, LLP | 20,307 | $26.4K | 0.00% | +20,307 | New |
| Prudential Financial Inc | 24,400 | $31.7K | 0.00% | +8,200+50.6% | Added |
| Man Group plc | 24,479 | $31.8K | 0.00% | +6,580+36.8% | Added |
| Ergoteles LLC | 28,507 | $37.1K | 0.00% | −59,667−67.7% | Reduced |
| Eversept Partners, LP | 31,172 | $40.5K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 32,279 | $42.0K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 34,883 | $45.3K | 0.00% | −36,161−50.9% | Reduced |
| Russell Investments Group, Ltd. | 40,195 | $52.3K | 0.00% | −24,800−38.2% | Reduced |
| State Street Corp | 48,737 | $63.4K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 78,439 | $102.0K | 0.00% | −826−1.0% | Reduced |
| Marquette Asset Management, LLC | 97,835 | $127.2K | 0.04% | +34,056+53.4% | Added |
| Privium Fund Management (UK) Ltd | 116,516 | $151.5K | 0.12% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 154,076 | $200.0K | 0.00% | +11,853+8.3% | Added |
| Bridgeway Capital Management, LLC | 187,600 | $243.9K | 0.01% | +74,400+65.7% | Added |
| Assenagon Asset Management S.A. | 225,816 | $294.0K | 0.00% | −54,165−19.3% | Reduced |
| Millennium Management LLC | 243,401 | $316.0K | 0.00% | +125,022+105.6% | Added |
| BlackRock Inc. | 273,113 | $355.0K | 0.00% | −170,083−38.4% | Reduced |
| Oasis Management Co Ltd. | 280,000 | $364.0K | 0.08% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 283,028 | $367.9K | 0.00% | +270,883+2,230.4% | Added |
| Tang Capital Management LLC | 400,000 | $520.0K | 0.08% | +200,000+100.0% | Added |
| Hawkeye Capital Management, LLC | 415,039 | $539.6K | 0.50% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 441,539 | $574.0K | 0.00% | +47,681+12.1% | Added |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $935.5K | 0.10% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 771,059 | $1.00M | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 928,276 | $1.21M | 0.00% | −11,993−1.3% | Reduced |
| Samsara BioCapital, LLC | 1,049,153 | $1.36M | 0.29% | 00.0% | Unchanged |
| Newtyn Management, LLC | 1,150,000 | $1.50M | 0.31% | +550,000+91.7% | Added |
| Nan Fung Group Holdings Ltd | 1,166,952 | $1.52M | 1.05% | 00.0% | Unchanged |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $2.46M | 1.07% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,752,162 | $3.58M | 0.00% | +1140.0% | Added |
| Sofinnova Investments, Inc. | 2,754,437 | $3.58M | 0.22% | 00.0% | Unchanged |
| Vivo Capital, LLC | 3,871,291 | $5.03M | 0.61% | 00.0% | Unchanged |
| Novo Holdings A/S | 0 | $0 | 0.00% | −3,703,991−100.0% | Sold out |
| Suvretta Capital Management, LLC | 0 | $0 | 0.00% | −2,672,000−100.0% | Sold out |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −533,432−100.0% | Sold out |
| Caas Capital Management LP | 0 | $0 | 0.00% | −116,777−100.0% | Sold out |
| Bailard, Inc. | 0 | $0 | 0.00% | −46,383−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −35,561−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −25,380−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −19,200−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −19,286−100.0% | Sold out |
| Dimensional Fund Advisors LP | 0 | $0 | 0.00% | −10,071−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −10,228−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −353−100.0% | Sold out |
| Ellevest, Inc. | 0 | $0 | 0.00% | −32−100.0% | Sold out |